ADVISORY COMMITTEE FOR PHARMACEUTICAL SCIENCE
Clinical Pharmacology Subcommittee
CDER Advisory Committee Conference Room
Day 2 -
Call to Order Jurgen Venitz, M.D., Ph.D., Chair
Conflict of Interest Kathleen Reedy, Exec.Sec.
Introduction to Topics for Day 2
Topic # 3 Pharmacogenetics: Improvement
of existing drug treatments Lawrence Lesko, Ph.D.,
Topic # 4 Drug interactions: Metabolism
and transport-based Shiew-Mei Huang, Ph.D.
Open Public Hearing
Concluding Remarks - Second Day Meeting